Regenerative medicine isn’t just a trending topic—it’s reshaping the entire healthcare landscape. In a recent discussion, Bradley Bostic and Chris Gandy tackle this rapidly evolving field, focusing on how it impacts medical professionals, patients, and the healthcare business itself. With rising frustrations among healthcare providers over declining reimbursements and the risk-heavy nature of traditional practices, Chris has found a unique approach to adapt while empowering his clients to make impactful choices.

For those unfamiliar, regenerative medicine emphasizes the body’s ability to heal itself. This includes therapies like peptides, stem cells, and treatments aimed at restoring function without invasive procedures. Chris notes a profound shift: many seasoned surgeons and anesthesiologists are pivoting to regenerative practices, recognizing that the high-stakes environment of Western medicine often comes with shrinking margins and intense liability. "I’ve seen seasoned professionals turn to regenerative medicine, not just for the income streams but for a fresh, proactive approach to healthcare," Chris explains. In his experience, the shift isn’t merely financial—it’s philosophical.

Bradley is quick to agree, underscoring how this approach aligns with the modern medical landscape, where private practices are often absorbed by larger organizations, leading to reduced independence for many physicians. As Chris puts it, the allure of “being able to help people without having to cut them open” is a game-changer. It’s this shift that has led to a boom in practices offering regenerative options, even as traditional models see increased consolidation and constraints.

Chris’s own story highlights the personal side of regenerative medicine. Following a sports injury, he found himself exploring alternative paths to healing—ones that didn’t rely on the typical pharmaceutical or surgical interventions. “I needed to find a way to stay active without compromising my body’s longevity,” he says. His exploration of regenerative techniques has become a lifestyle, encompassing everything from stem cell therapies to cutting-edge physical regimens like hot yoga. This journey has enabled him to help others, particularly former athletes, to find sustainable health solutions that extend far beyond the sports field.

Beyond the physical, Chris also touches on the mental resilience that regenerative medicine brings. He describes the phenomenon where many patients, himself included, find renewed energy and clarity. This aligns well with studies showing that proactive health measures not only improve physical wellness but mental acuity. For Bradley, this isn’t just an emerging trend—it’s a philosophical shift. He adds that individuals willing to adopt preventative, health-focused habits are often better equipped to handle life’s pressures, both personally and professionally.

This type of medicine, however, isn’t accessible to all. Regenerative treatments are largely cash-based, putting them out of reach for many. Yet, Chris argues that the value they bring, in terms of reduced downtime and improved quality of life, is unparalleled. “If you’re considering regenerative options, start by consulting with a trusted physician,” he advises, emphasizing that expertise is paramount in this field, where unqualified practitioners can often get it wrong.

The conversation also delves into the impact of financial literacy on healthcare. Chris helps his clients in the medical field navigate these new waters, often advising on how to make wise choices in both their professional and personal lives. He believes that healthcare providers who are financially empowered make better, more ethical decisions—another reason why regenerative medicine’s business side matters. Bradley sees this blend of finance and medicine as pivotal, as it ensures doctors retain autonomy while maximizing impact.

Bradley and Chris’s discussion is a

In an era where healthcare increasingly embraces personalization, Bradley Bostic and Lisa Huse are at the forefront, advocating for a shift in patient care that’s both effective and tailored. Their conversation isn’t just about innovation; it’s about making healthcare meet the unique needs of each patient. They explore a new kind of patient experience—one where traditional trial-and-error approaches are left behind, replaced by diagnostics and therapies that fit each individual.

Lisa’s extensive experience, particularly in diabetes care with Roche, gives her insights a grounded credibility. She understands that managing diabetes is about more than just medication. As she puts it, “It was about personalization and helping people find their own version of what good looked like.” This isn’t an easy path; the transition from standard methods to personalized care requires shifting entire systems and mindsets, something she and Bradley both passionately advocate for.

When managing diabetes, the challenge goes beyond merely prescribing treatments. Lisa discusses her work with Roche in a world where devices and apps are not always integrated. As she explains, many people face “disparate pieces and parts where one diagnostic product didn't talk to the therapeutic product.” This lack of connectivity can prevent patients from seeing the full picture of their health. It’s here where Lisa saw the potential to change lives—working on models to guide patients toward sustainable behavior changes, which, as she mentions, “feels realistic and something they could accomplish.”

For those navigating diabetes, or any chronic condition, this kind of behavioral support is essential. "Diabetes in many situations is a behavioral disease," Lisa says, stressing that while medication is critical, it isn’t the full solution. She and Bradley explore how success lies in creating a system where patients are motivated by personal goals—like walking a daughter down the aisle—rather than abstract medical advice. The conversation brings into focus the question: How do we enable patients to take control without overwhelming them?

Bradley's interest in this subject isn’t just theoretical. As the founder of hc1, he’s been a transformative figure, guiding his company to become a leader in using AI to analyze lab data, ensuring that each patient gets the treatment they need, at the time they need it. His experience underscores the need for an approach that combines empathy with innovation.

One key topic Lisa highlights is the evolution from clinic-centered care to care at home. Technology is paving the way for home diagnostics and telehealth to improve accessibility and outcomes. As Lisa describes, the future of healthcare is not in prescribing more but in enabling patients to “engage the healthcare community that surrounds you.” It’s a vision where patients work with healthcare professionals in a more collaborative and personalized way—one that doesn’t sacrifice individual needs for a one-size-fits-all solution.

For Lisa and Bradley, the future of healthcare must balance innovation with economic feasibility. Healthcare may be a trillion-dollar industry, but introducing new models of care often meets with financial resistance. As Bradley notes, the industry is a “zero-sum game” where economic incentives are paramount. Without a financial structure that supports innovations like those Lisa champions, the most groundbreaking ideas risk being shelved.

The discussion also underscores the importance of keeping the clinician in the loop. Even with advancements in telehealth and AI, Lisa emphasizes that “diagnosing any condition requires a clinician,” ensuring accuracy and context. This human element, coupled with the power of technology, is where Lisa sees the true potential for change.

As our healthcare system faces shortages of trained...